TG Therapeutics, Inc. (TGTX)
30.43
-0.40
(-1.30%)
USD |
NASDAQ |
Dec 09, 16:00
30.44
+0.01
(+0.03%)
After-Hours: 20:00
TG Therapeutics Shareholders Equity (Quarterly): 607.22M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Karyopharm Therapeutics, Inc. | -269.26M |
| Axsome Therapeutics, Inc. | 73.73M |
| Krystal Biotech, Inc. | 1.138B |
| Arcutis Biotherapeutics, Inc. | 158.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.025B |
| Total Liabilities (Quarterly) | 417.81M |
| Debt to Equity Ratio | 0.4178 |
| Current Ratio | 3.825 |
| Net Debt Paydown Yield | -0.50% |